loader2
Partner With Us NRI

Amrutanjan Health Care Ltd share Price Today

Company details

670.00
677.05
563.90
775.45
6M Return 13.66%
1Y Return 11.65%
Mkt Cap.(Cr) 1,943.25
Volume 9,145
Div Yield 0.69%
OI
-
OI Chg %
-
Volume 9,145

Open Free Trading Account Online with ICICIDIRECT

Incur '0' Brokerage upto ₹500

Pharmaceuticals firm Amrutanjan Health Care announced Q1FY23 Result :

  • Key raw material prices excluding Menthol crystal price are higher when compared to Q1 FY22.
  • The prices of packing materials are higher when compared to Q1 FY22.
  • Advertisement spend for Q1 FY23 is at Rs.5.20 cr against Rs.4.28 cr for Q1 FY22. Advertisement spend for Comfy is at 3.90 cr for Q1 FY23 against 3.31 cr for Q1 FY22.

 

Result PDF

View Other Company Results

Amrutanjan Health Care Ltd shares SWOT Analysis

Strengths (8)

  • Strong Momentum: Price above short, medium and long term moving averages
  • Growth in Net Profit with increasing Profit Margin (QoQ)
  • Company with No Debt

Weakness (4)

  • Inefficient use of capital to generate profits - RoCE declining in the last 2 years
  • Inefficient use of shareholder funds - ROE declining in the last 2 years
  • Inefficient use of assets to generate profits - ROA declining in the last 2 years

Opportunity (1)

  • RSI indicating price strength

Threats (1)

  • High PE (PE > 40)

Resistance and support

R1 684.3
R2 695.4
R3 702.5
Pivot

677.15

S1 666.0
S2 658.9
S3 647.8
EMA SMA
649.4
637.2
627.9
629.5
643.6
641.7
618.2
624.6
Delivery and volume
CLIENT NAME DEAL TYPE ACTION DATE AVG. PRICE QUANTITY EXCHANGE
GRAVITON RESEARCH CAPITAL LLP Bulk Purchase 2023-06-30 737.21 191539 NSE
GRAVITON RESEARCH CAPITAL LLP Bulk Sell 2023-06-30 737.86 191539 NSE
N.K.SECURITIES Bulk Purchase 2020-06-10 384.97 371237 NSE
Name Category Shares
SAMBHU PRASAD SIVALENKA PROMOTER 3.6%
RAMAA P ARIKIREVULA PROMOTER 3.02%
AMULYA KAMAKSHI PRIYA ARIKIREVULA PROMOTER 2.13%
GOODHEALTH HOLDINGS PRIVATE LIMITED PROMOTER 20.15%
SAMBHUPRASAD SIVALENKA PROMOTER 10.34%
SATHYANARAYANA MURTHI PASUMARTHI PROMOTER 8.68%
RAMALINGAM GANTI PROMOTER 2.53%

FINANCIALS

Sales
Operating Profit
Profit after Tax
Equity
Reserves and Surplus
Debt
Sales
Operating Profit
Profit after Tax
PE
Debt/Equity
P BV

Amrutanjan Health Care Ltd Stocks COMPARISON

Financials( in Cr) Amrutanjan Health Care Ltd Sun Pharmaceuticals Industries Ltd Cipla Ltd Divis Laboratories Ltd Dr Reddys Laboratories Ltd
Price 672.15 1,490.85 1,381.30 3,806.45 5,982.00
% Change -0.14 0.42 2.57 1 0.50
Mcap Cr 1,943.25 357,704.86 111,521.60 101,049.45 99,790.53
Revenue TTM Cr 379.64 43,885.68 15,790.60 7,767.51 24,669.70
Net Profit TTM Cr 39.83 8,560.84 2,513.47 1,823.38 4,507.30
PE TTM 44.33 37.95 27.52 72.36 19.00
1 Year Return 11.65 52.26 52.97 19.22 24.47
ROCE 18.81 16.79 14.76 19.30 25.99
ROE 14.33 16.46 10.66 14.89 21.21
INSIDER & INSTITUTIONAL ACTIVITY

Equity Capital: 290.77 Cr FV: 1.00

Period MF Net Purchase / (sold) FII Net
LAST 1M 19,463.02 -6,228.06
LAST 3M 77,954.71 28,409.22
LAST 6M 138,694.84 74,737.91
LAST 12M 215,251.82 194,497.84

Amrutanjan Health Care Ltd Information

Stock PE (TTM)
44.33
Promoter Holding
50.59%
Book Value
90.6251
ROCE
18.81%
ROE
14.33%
Description
  • The Madras-based Amrutanjan manufactures bulk drugs and drug intermediateslike theophylline, based on in-house research. Three plants have been set up in the Alandur industrial belt near Madras to produce these products. It recently entered into a joint venture with Welsh firm Cardiff Chemicals to manufacture pheromones (a type of agrochemicals) at Cuddalore. Pheromones have found wide application as pesticides and are used on cotton crops. Amrutanjan also has an agreement with a company in Philadelphia, US, to supply custom-made chemicals for exotic applications like the genetic manipulation of biological matter. It has introduced some new range of products like Pep Pill, Amrutanjan gripe water sans alcohol, Amrutanjan Maha Strong, etc. Plans are afoot to introduce analgesic and antipyretic tablets. The company also plans to launch sanitary napkins soon. The company has approached the US FDA for approval and clearance to sell its new drugs in US. During 1996-97, it has introduced a new product called `Cold Snap Gel` and also a mint called `tingle`. Company having two subsidiary companies viz. Amrutanjan Drugs & Chemicals Ltd having holding stake 99.80% & Amrutanjan Finance Ltd, having holding stake is 57.26%. Company has taken efforts to increase the export of fine chemicals & also taking major efforts to give full thrust to existing products. Amrutanjan also modernising its OTC business and expanding its export of fine chemicals which reflects to turnover & net Profit of the Company. `Diakyur` for the treatment of Diabetes was introduced during 2000-2001 and it has been well accepted by the customers. The company`s R & D has been engaged in the development of neutraceuticals.The company is mainly focussing on Bio-Tech products and expects a good results from this division. During 2001-02 the company allotted 16,00,000 equity bonus shares of Rs.10/- each and subsequently the share capital has increased from Rs.1.60 crores to Rs.3.20 crores.

Registered Address

New 103 Old 42-45 LuzChurch Rd, Mylapore, Chennai, Tamil Nadu, 600004

Tel : 91-44-24994164/24994465/24994366
Email : investors:amrutanjan.com; customercare:amrutanjan.
Website : http://www.amrutanjan.com
Registrar

Cameo Corporate Services Ltd

AGM Date (Month) : Sep
Face Value Equity Shares : 1
Market Lot Equity Shares : 1
BSE Code : 590006
NSE Code : AMRUTANJAN
Book Closure Date (Month) : Sep
BSE Group : B
ISIN : INE098F01031

FAQ’s on Amrutanjan Health Care Ltd Shares

You can buy Amrutanjan Health Care Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Amrutanjan Health Care Ltd Share.

Company share prices and volatile and keep changing according to the market conditions. As of Apr 24, 2024 11:19 AM the closing price of Amrutanjan Health Care Ltd was ₹ 672.15.

Market capitalization or market cap is determined by multiplying the current market price of a company’s shares with the total number of shares outstanding. As of Apr 24, 2024 11:19 AM, the market cap of Amrutanjan Health Care Ltd stood at ₹ 1,943.25.

The latest PE ratio of Amrutanjan Health Care Ltd as of Apr 24, 2024 11:19 AM is 44.33

The latest PB ratio of Amrutanjan Health Care Ltd as of Apr 24, 2024 11:19 AM is 0.13

The 52-week high of Amrutanjan Health Care Ltd share price is ₹ 775.45 while the 52-week low is ₹ 563.90

Download Our

Download App
market app